Income Statement (TTM)
Matinas BioPharma Holdings, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 1 | 2 | 3 | 4 | 3 | 2 | 1 | 0 | 0 | 0 |
| Change (%) | 65.22 | 21.05 | 0.00 | -50.00 | -65.57 | -101.01 | -319,219.22 | 99.94 | 50.05 | 34.38 | -24.81 | -32.97 | -49.24 | -100.00 | NaN | NaN | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |||
| Cost Of Sales | 14 | 14 | 14 | 13 | 14 | 15 | 16 | 18 | 17 | 14 | 13 | 15 | 15 | 14 | 14 | 14 | 13 |
| Change (%) | 0.74 | -5.89 | -6.88 | 10.21 | 5.15 | 11.91 | 10.09 | -5.09 | -16.26 | -7.06 | 13.81 | -2.73 | -1.37 | -3.62 | -1.35 | -7.65 | |
| % of Revenue | 14,872.80 | 9,068.81 | 7,050.53 | 6,565.58 | 14,472.07 | 44,190.91 | -4,900,771.77 | 1,690.63 | 802.50 | 447.87 | 309.76 | 468.89 | 680.45 | 1,321.99 | |||
| Gross Operating Profit | -14 | -14 | -13 | -12 | -14 | -15 | -16 | -17 | -15 | -11 | -9 | -12 | -13 | -13 | -14 | -14 | -13 |
| Change (%) | 0.31 | -6.19 | -6.98 | 11.14 | 5.64 | 12.16 | 3.57 | -11.70 | -25.70 | -18.97 | 32.23 | 5.47 | 6.87 | 4.27 | -1.35 | -7.65 | |
| % of Revenue | -14,772.80 | -8,968.81 | -6,950.53 | -6,465.59 | -14,372.07 | -44,090.91 | 4,900,870.87 | -1,590.63 | -702.50 | -347.87 | -209.76 | -368.89 | -580.45 | -1,221.99 | |||
| SG&A | 9 | 10 | 11 | 11 | 11 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 10 | 9 |
| Change (%) | 7.63 | 8.85 | -0.44 | -0.99 | -5.14 | -3.94 | 5.65 | 5.43 | 1.85 | -0.29 | -2.38 | 0.20 | -4.19 | -2.47 | -1.28 | -6.99 | |
| % of Revenue | 9,700.66 | 6,319.57 | 5,682.46 | 5,657.74 | 11,203.28 | 30,863.64 | -2,938,135.14 | 972.75 | 512.95 | 348.18 | 258.36 | 335.45 | 501.48 | 946.44 | |||
| R&D | 2 | 2 | |||||||||||||||
| Change (%) | 0.00 | ||||||||||||||||
| % of Revenue | 75.28 | 56.02 | |||||||||||||||
| OpEx | 24 | 24 | 24 | 23 | 25 | 25 | 26 | 28 | 28 | 28 | 27 | 26 | 26 | 25 | 24 | 24 | 22 |
| Change (%) | 3.46 | 0.16 | -4.00 | 5.03 | 0.66 | 5.39 | 8.43 | -1.25 | -0.61 | -3.74 | -3.10 | -1.51 | -2.57 | -3.14 | -1.32 | -7.37 | |
| % of Revenue | 24,573.46 | 15,388.38 | 12,732.99 | 12,223.33 | 25,675.35 | 75,054.55 | -7,838,906.91 | 2,663.38 | 1,315.45 | 871.33 | 624.14 | 804.35 | 1,181.94 | 2,268.43 | |||
| Operating Income | -23 | -24 | -24 | -23 | -25 | -25 | -26 | -27 | -26 | -25 | -22 | -23 | -23 | -24 | -24 | -24 | -22 |
| Change (%) | 3.21 | 0.03 | -4.03 | 5.48 | 0.92 | 5.53 | 4.35 | -5.20 | -4.78 | -8.69 | 1.04 | 2.96 | 1.74 | 1.33 | -1.32 | -7.37 | |
| % of Revenue | -24,473.46 | -15,288.38 | -12,632.99 | -12,123.32 | -25,575.36 | -74,954.55 | 7,839,006.01 | -2,563.38 | -1,215.45 | -771.33 | -524.14 | -704.35 | -1,081.94 | -2,168.43 | |||
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -5.41 | -14.29 | -16.67 | -0.00 | -40.00 | -0.00 | -33.33 | -100.00 | -∞ | -0.00 | 100.00 | 50.00 | -0.00 | -0.00 | -33.33 | 50.00 | |
| % of Revenue | -7.72 | -4.42 | -3.13 | -2.61 | -5.22 | -9.09 | 900.90 | -0.19 | 0.00 | -0.03 | -0.02 | -0.06 | -0.14 | -0.27 | |||
| Net Income | -22 | -22 | -22 | -22 | -23 | -23 | -24 | -25 | -24 | -21 | -21 | -21 | -21 | -23 | -23 | -23 | -21 |
| Change (%) | 3.54 | -0.40 | -3.67 | 6.44 | 1.56 | 4.39 | 4.66 | -5.40 | -12.74 | -2.21 | 0.67 | 2.87 | 7.90 | 1.36 | -1.47 | -7.77 | |
| % of Revenue | -22,621.42 | -14,176.98 | -11,664.70 | -11,237.16 | -23,921.68 | -70,554.55 | 7,298,702.70 | -2,393.65 | -1,132.51 | -658.63 | -479.27 | -641.70 | -984.81 | -2,093.25 | |||
Source: Capital IQ
